Sign in to view content

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch

Estephania Feria, MD

Video
Published 2019

Related

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Fovea-Sparing Rhegmatogenous Retinal Detachments: Impact of Clinical Factors Including Time to Surgery on Visual and Anatomic Outcomes
James C. Major, MD, PhD FACS FASRS
Annual Meeting Talks
2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss
Jennifer K. Sun, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more